L. A. Rybicki
About
In The Last Decade
L. A. Rybicki
18 papers receiving 723 citations
Peers
Comparison fields: 5 of 73
- Epidemiology 436
- Hepatology 266
- Genetics 149
- Surgery 141
- Oncology 115
Countries citing papers authored by L. A. Rybicki
This map shows the geographic impact of L. A. Rybicki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. A. Rybicki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. A. Rybicki more than expected).
Fields of papers citing papers by L. A. Rybicki
This network shows the impact of papers produced by L. A. Rybicki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. A. Rybicki. The network helps show where L. A. Rybicki may publish in the future.
Co-authorship network of co-authors of L. A. Rybicki
This figure shows the co-authorship network connecting the top 25 collaborators of L. A. Rybicki. A scholar is included among the top collaborators of L. A. Rybicki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. A. Rybicki. L. A. Rybicki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 4 | |
| 5 | 1 | |
| 6 | 3 | |
| 7 | 95 | |
| 8 | 15 | |
| 9 | 1 | |
| 10 | 109 | |
| 11 | 16 | |
| 12 | 60 | |
| 13 | Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations. | 265 |
| 14 | 0 | |
| 15 | 2 | |
| 16 | 56 | |
| 17 | 3 | |
| 18 | Multiple red cell transfusions and alloimmunization. Experience with 6996 antibodies detected in a total of 159,262 patients from 1985 to 1993. | 104 |
| 19 | Clinical evaluation of the efficacy and safety of the UltraSonex ultrasonic toothbrush: a 30-day study. | 17 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.